FORMULATION AND CHARACTERIZATION OF GRISEOFULVIN LOADED LIPOSOMES USING QUALITY BY DESIGN (QBD) APPROACH

Main Article Content

Indra Kumar
Kapil Malviya
Pushpendra Soni
Pushpendra Kumar
Lavakesh Kumar Omray

Keywords

QbD, optimization liposome, antifungal, griseofulvin

Abstract

The objective of the present investigation was to formulate liposomes of griseofulvin using quality by design (QbD) approach and evaluate the formulation for various parameters. A D-optimal experiment design with two independent and two dependent variables was used to optimize the formulation with the best QTPP. Phospholipid concentration, phospholipid to stearyl alcohol molar ratio were selected as the critical parameters affecting the desired CQAs. The effect of phospholipid concentration and the ratio of phospholipid to stearyl alcohol was statistically validated using ANOVA and the 2 factorial model depicted a significant F-value of 35.83 for entrapment efficiency. The model presented a regression coefficient value of 0.9896 and adequate precision value of 17.274. The particles of the optimized liposome were found to be having an average particle size of 149.1 nm with a poly dispersity index of 0.428 and a zeta potential of -17.1 mV. The entrapment efficiency was found to be 72.71 ± 1.047 % (n=3). The in vitro release showed that the optimal liposomal formulation released only 74.78 ± 1.8680 % griseofulvin after 72 h. The formulation was subjected to stability analysis for 28 days and the amount of griseofulvin retained in the formulation was considered as the stability indicator. It was seen that around 3.08% drug was lost in the 28 days of keeping the formulation.

Abstract 139 | Pdf Downloads 82

References

1. https://learnaboutgmp.com/good-validation-practices/pharmaceutical-quality-by-design-qbd-an-introduction-process-development-and-applications/ assessed on 30/10/2020
2. Lengert EV, Verkhovskii RA, Genina EA, Terentyuk GS, Svenskaya YI. Mesoporous particles for transdermal delivery of the antifungal drug griseofulvin. Journal of Physics: Conf. Series 2020; 1461: 012083
3. Sandy GM, Long CM, Kah LS, Kah YH. Influence of the EncapsulationEfficiency and Size of Liposome on the Oral Bioavailability of Griseofulvin-Loaded Liposomes. Pharmaceutics 2016; 8: 25-33
4. Bavarsad N, Kouchak M, Mohamadipour P, Nejad BS. Preparation and physicochemical characterization of topical chitosan‑based film containing griseofulvin‑loaded liposomes. Journal of Advanced Pharmaceutical Technology and Research 2016; 7: 91-8.
5. Liu P, Chen G, Zhang J. A Review of Liposomes as a Drug Delivery System: Current Status of Approved Products, Regulatory Environments, and Future Perspectives. Molecules. 2022; 27: 1372. Doi: 10.3390/molecules27041372.
6. Lakshmi Andra VVSN, Pammi SVN, Krishna Priya Bhatraju LV, Ruddaraju LK. A Comprehensive Review on Novel Liposomal Methodologies, Commercial Formulations, Clinical Trials and Patents. BioNanoScience. 2022; 12: 2749-291. Doi: 10.1007/s12668-022-00941-x
7. Liu Q, Cai W, Zhen T, Ji N, Dai L, Xiong L, et al. Preparation of debranched starch nanoparticles by ionic gelation for encapsulation of epigallocatechin gallate. Int J Biol Macromol. 2020; 161: 481–91.
8. Chu C, Deng J, Man Y, Qu Y. Green tea extracts epigallocatechin-3-gallate for different treatments. Biomed Res Int. 2017; 2017.
9. Yang K, Delaney JT, Schubert US, Fahr A. Fast high-throughput screening of temoporfin-loaded liposomal formulations prepared by ethanol injection method. J Liposome Res. 2012;22(1):31–41.
10. Nkanga CI, Bapolisi AM, Okafor NI, Krause RWM. General perception of liposomes: formation, manufacturing and applications. In: Liposomes—advances and perspectives. IntechOpen; 2019.